Recent studies have found that the amount of tau deposition is more associated with disease stages and severity of AD as compared to the accumulation of amyloid-beta plaque (Aß) (Pichet Binette et al. 2022; Hanseeuw et al. 2019). This evidence concerns the gene MAPT and Alzheimer disease.